The biotech company Lorus has announced the enrollment of the first cancer patient in a Phase I clinical study evaluating its small molecule anticancer drug candidate LOR-253. The open-label, dose escalation study will enroll patients with advanced or metastatic solid tumors for which no effective therapy is currently available, or whose cancer has not responded to conventional or standard ther...

The journal Cancer Epidemiology, Biomarkers & Prevention (CEBP) has launched a new manuscript section entitled Cancer Surveillance Research (CSR). The CSR section will consist of original reports using cancer case and population data to examine, test, and develop hypotheses for cancer prevalence, incidence, and mortality. The scope of CSR includes descriptive epidemiology, public health statist...

The availability of a biological resource such as human tissue and its derivatives for research that is fit for purpose and linked to well-annotated clinical data under approved ethical protocols is an essential facility for biomedical research, especially in the present era of personalized, translational medicine. The importance of these facilities have been recognized in the popular media wit...

What is it famous for? The Cancer Research Campaign (CRC) is one of two rival charities that dominate cancer research funding in the UK — the other being the Imperial Cancer Research Fund (ICRF). But most British people are probably more aware of the CRC's charity shops, which are on almost every high street. How did it begin? In 1923, a group of clinicians, who felt that the work of the ICRF h...

review:background: liver cancer is the sixth most common cancer and the third leading cause of cancer is. the true prevalence of infection in cancer remains unknown but the incidence of these cancers in 1.7 % of all cases of cancer. the aim of this study was to examine the changes of liver cancer mortality in the population during the years 2006 to 2010.materials and methods: in this study, the...